After reconstitution, DSIP should be refrigerated for short-term stability
Other research categories GLP-1 / GLP-3 Receptor Agonists Incretin-mimetic peptides studied for glucose homeostasis, energy balance, and metabolic regulation
Results may fade if supplementation or treatment stops
In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
Ved topisk bruk rapporteres GHK-Cu bivirkninger sjelden, men noen individer opplever: Ved injiserbar bruk er de vanligste rapporterte erfaringene: Det finnes lite data p bruk av GHK-Cu under graviditet og amming gravide og ammende br unng injiserbar bruk
Downsides to potential peptides ban Why you should care: If the FDA enforces a strict ban, patients managing conditions like colitis, depression, severe inflammation, and sleep disorders through custom peptide therapies could lose access to their treatments overnight